|
⚲
|
| Keyboard |
| John Mendlein | |
|---|---|
| Firm | |
| Address | c/o Fate Therapeutics, Inc 3535 General Atomics Court, Suite 200 San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Fate Therapeutics Inc | 021-370287 | Director | 50.0 M of 50.0 M |
||
| Fate Therapeutics Inc | 021-365465 | Director | 50.0 M of 50.0 M |
||
| ATYR Pharma Inc | 021-294795 | Executive Officer | 45.8 M of 45.8 M |
||
| Fate Therapeutics Inc | 021-275847 | Director | 56.7 M of 56.7 M |
||
| Moderna Therapeutics Inc | 021-269500 | Director | 451.4 M of 600.0 M |
||
| Fate Therapeutics Inc | 021-269268 | Director | 10.3 M of 10.3 M |
||
| Axcella Health Inc | 021-258026 | Director | 42.5 M | ||
| Fate Therapeutics Inc | 021-240107 | Director | 8.0 M of 8.0 M |
||
| ATYR Pharma Inc | 021-237156 | Executive Officer | 76.3 M of 76.3 M |
||
| Pronutria Biosciences Inc | 021-234192 | Director | 44.3 M | ||
| Moderna LLC | 021-231445 | Director | 446.1 M of 502.2 M |
||
| Moderna LLC | 021-206659 | Director | 135.0 M of 135.0 M |
||
| Fate Therapeutics Inc | 021-201262 | Director | 20.0 M of 20.0 M |
||
| Fate Therapeutics Inc | 021-183005 | Director | 9.2 M | ||
| Fate Therapeutics Inc | 021-158650 | Executive Officer | 1.0 M of 1.0 M |
||
| Chimeros Inc | 021-151372 | Director | 0.8 M of 0.8 M |
||
| Fate Therapeutics Inc | 021-117892 | Executive Officer | 36.0 M of 36.0 M |
||
| Chimeros Inc | 021-81929 | Director | 0.4 M of 0.5 M |
||